Last updated: July 21, 2025
Sponsor: Ankara Yildirim Beyazıt University
Overall Status: Completed
Phase
N/A
Condition
Thrombosis
Chest Pain
Heart Disease
Treatment
Progressive muscle relaxation
Clinical Study ID
NCT06524999
AnkaraYBU-SBF-TTK-02
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
undergo CAG for the first time
has a chest score of 5 or less on the pain scale
has no history of mental disorder according to medical records
is able to communicate
Exclusion
Exclusion Criteria:
Admission to the intensive care unit after the CAG procedure
starting analgesic or perlinganit infusion
wanting to quit the research
Study Design
Total Participants: 70
Treatment Group(s): 1
Primary Treatment: Progressive muscle relaxation
Phase:
Study Start date:
June 01, 2022
Estimated Completion Date:
December 31, 2022
Study Description
Connect with a study center
Ankara Yildirim Beyazıt University
Ankara, Çubuk 06760
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.